Related Experiment Videos
Financial Toxicity in Crohn's Disease
Antanina Voit1, Raymond K Cross2, Emily Bellavance1
1Departments of Surgery.
Journal of Clinical Gastroenterology
|October 26, 2018
Summary
Financial toxicity is common in Crohn's disease (CD) patients, with lower income and education worsening financial distress. Anxiety and depression also increase financial burden in CD patients.
Area of Science:
- Gastroenterology
- Health Economics
- Patient-Reported Outcomes
Background:
- The Comprehensive Score for Financial Toxicity (COST) is a validated patient-reported outcome measure for cancer patients.
- Financial toxicity is a significant concern impacting patient well-being and treatment adherence.
Purpose of the Study:
- To evaluate the prevalence and correlates of financial toxicity in patients with Crohn's disease (CD).
- To assess the impact of sociodemographic and clinical factors on financial distress in CD.
Main Methods:
- A cross-sectional survey administered the COST questionnaire to 48 CD patients at a tertiary care center.
- Data on sociodemographics, clinical characteristics, and disease activity were collected.
- Statistical analysis was performed using Minitab.
Main Results:
- The median COST score indicated mild negative impact on quality of life for CD patients.
- Financial toxicity was significantly associated with lower education, unemployment, disability, lower income, and housing status.
- Higher disease activity, anxiety, and depression correlated with increased financial distress.
Conclusions:
- A majority of surveyed CD patients experience financial distress.
- Lower socioeconomic status and mental health comorbidities exacerbate financial toxicity in CD.
- Interventions are needed to mitigate financial toxicity in the Crohn's disease population.